NCT00470509View on ClinicalTrials.gov

Adalimumab in Severe and Acute Sciatica

PHASE2CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

January 31, 2008

Study Completion Date

June 30, 2008

Conditions
Sciatica
Interventions
DRUG

Adalimumab

2 subcutaneous injections on day 0 and 7

DRUG

Placebos

2 subcutaneous injections on day 0 and 7

Trial Locations (1)

1211

Geneva University Hospital, Geneva

All Listed Sponsors
lead

University Hospital, Geneva

OTHER

NCT00470509 - Adalimumab in Severe and Acute Sciatica | Biotech Hunter | Biotech Hunter